Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03329066 · ClinicalTrials.gov registry record · NA
Sleep Quality in High School Students With Asthma - II
A NA study of Asthma and Sleep, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 2
- Study locations
NCT03329066: Completed NA study of Asthma and Sleep, sponsored by Columbia University.
NCT03329066 is a NA study of Asthma and Sleep that has completed, run by Columbia University. The registered enrollment target is 63 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03329066, a NA study of Asthma and Sleep, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall goal of this project is to develop and to preliminarily validate a novel intervention to be delivered in the high school setting that integrates two evidence-based, school-based interventions for urban adolescents with proven efficacy: (1) Asthma Self-Management for Adolescents (ASMA), an intervention for adolescents with uncontrolled asthma and (2) the Sleep-Smart Program (Sleep-Smart), which focuses on sleep hygiene and behaviors in urban adolescents. The aim for Phase I is to develop and integrate school-based interventions to improve asthma self-management and sleep hygiene in urban high school students via interviews. The aims for Phase II are: (1) to evaluate the feasibility and acceptability of the intervention procedures; and (2) to assess the preliminary evidence of the effects of the intervention on improving sleep quality in urban high school students with persistent asthma over a 2-month follow-up period. This record is for Phase II only.
Primary Outcome
Sleep efficiency will be calculated from data obtain from actigraphs (Model AW2; Mini Mittler) that the teenagers will wear for 2 weeks at each point.
Conditions Studied
Interventions
- BEHAVIORAL MAST - Managing Asthma & Sleep in Teens
- BEHAVIORAL ASMA - Asthma Self-Management for Adol
- BEHAVIORAL Information & Referral Control Group
Study Locations (2)
New York
- Columbia University - New York
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-04-09 |
| Est. Completion | 2019-12-12 |
| Phase | NA |
What the finished NCT03329066 record still lists
NCT03329066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which MAST - Managing Asthma & Sleep in Teens is the first listed.
NCT03329066 reports a single indexed study location in New York, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03329066 about?
NCT03329066 is a clinical study titled "Sleep Quality in High School Students With Asthma - II". The overall goal of this project is to develop and to preliminarily validate a novel intervention to be delivered in the high school setting that integrates two evidence-based, school-based interventions for urban adolescents with proven efficacy: (1) Asthma Self-Management for Adolescents (ASMA), a...
What is the current status of trial NCT03329066?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2018-04-09. Estimated completion is 2019-12-12.
What conditions does trial NCT03329066 study?
This clinical trial studies the following conditions: Asthma, Sleep, Asthma in Children.
What interventions are being tested in trial NCT03329066?
The interventions under investigation include: MAST - Managing Asthma & Sleep in Teens (BEHAVIORAL), ASMA - Asthma Self-Management for Adol (BEHAVIORAL), Information & Referral Control Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03329066?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03329066 being conducted?
This trial has 2 study locations across New York, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03329066's enrollment target sits among peer trials
63 246th of 374 higher than 129 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI